Arterra Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Arterra Bioscience has a total shareholder equity of €10.0M and total debt of €522.3K, which brings its debt-to-equity ratio to 5.2%. Its total assets and total liabilities are €12.4M and €2.3M respectively. Arterra Bioscience's EBIT is €767.6K making its interest coverage ratio -2.1. It has cash and short-term investments of €6.0M.
Key information
5.2%
Debt to equity ratio
€522.32k
Debt
| Interest coverage ratio | -2.1x |
| Cash | €6.01m |
| Equity | €10.05m |
| Total liabilities | €2.33m |
| Total assets | €12.38m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: ARBS's short term assets (€9.8M) exceed its short term liabilities (€1.2M).
Long Term Liabilities: ARBS's short term assets (€9.8M) exceed its long term liabilities (€1.1M).
Debt to Equity History and Analysis
Debt Level: ARBS has more cash than its total debt.
Reducing Debt: ARBS's debt to equity ratio has reduced from 35.6% to 5.2% over the past 5 years.
Debt Coverage: ARBS's debt is well covered by operating cash flow (267.2%).
Interest Coverage: ARBS earns more interest than it pays, so coverage of interest payments is not a concern.